Immune effector cell associated neurotoxicity syndrome ICANS

Module 2: Toxicity Assessment and Management | ICANS

Treating CRS and ICANS: current approaches and future outlooks

CAR-T Toxicities: CRS and ICANS

Immune-Cell Engineering with Mark Leick, MD

What is ICANS?

Let’s Take a BiTE Out of CRS and Neurotoxicity - B. Kikani - 20231018

Impact of age and co-morbidities on axi-cel efficacy

Managing Acute Toxicities of CAR T-cell Therapy

Cynthia Harrison, medical student, National Cancer Institute (NCI)

2022 ICD-10-CM New, Changed, Revised and Updated Codes

Results from a Phase I/II trial of pirtobrutinib and LV20.19 for patients with R/R lymphomas

Challenges and Considerations in Designing and Conducting Immuno--Oncology Clinical Research

What's New in ICD 10 CM?

ICD-10-CM: 2022 Code Changes

aggressive lymphoma SOHO 2021 Better quality

The Future of ICD-10-CM/PCS has Arrived: Insight into the 2022 ICD-10 Code Sets

ICD-10-CM Code Updates for 2022- Medical Coding Changes

Cellular therapy - a post ASH 2020 summary

CD19 CAR T Cell Therapy for Pediatric ALL: The Seattle Children’s Experience